253 related articles for article (PubMed ID: 27647784)
21. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of nurse-led disease management for heart failure in an ethnically diverse urban community.
Hebert PL; Sisk JE; Wang JJ; Tuzzio L; Casabianca JM; Chassin MR; Horowitz C; McLaughlin MA
Ann Intern Med; 2008 Oct; 149(8):540-8. PubMed ID: 18936502
[TBL] [Abstract][Full Text] [Related]
23. Sacubitril/valsartan or an implantable cardioverter-defibrillator in heart failure with reduced ejection fraction patients: a cost-effectiveness analysis.
Zacà V
J Cardiovasc Med (Hagerstown); 2018 Oct; 19(10):597-605. PubMed ID: 30160656
[TBL] [Abstract][Full Text] [Related]
24. Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure.
Alkhatib N; Sweitzer NK; Lee CS; Erstad B; Slack M; Gharaibeh M; Karnes J; Klimecki W; Ramos K; Abraham I
Am J Cardiovasc Drugs; 2021 Mar; 21(2):205-217. PubMed ID: 32710439
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction.
Gaziano TA; Fonarow GC; Velazquez EJ; Morrow DA; Braunwald E; Solomon SD
JAMA Cardiol; 2020 Nov; 5(11):1236-1244. PubMed ID: 32785628
[TBL] [Abstract][Full Text] [Related]
26. Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis.
Jiang X; Yao J; You JH
JMIR Mhealth Uhealth; 2020 Jul; 8(7):e17846. PubMed ID: 32407288
[TBL] [Abstract][Full Text] [Related]
27. Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial.
Baron SJ; Wang K; Arnold SV; Magnuson EA; Whisenant B; Brieke A; Rinaldi M; Asgar AW; Lindenfeld J; Abraham WT; Mack MJ; Stone GW; Cohen DJ;
Circulation; 2019 Dec; 140(23):1881-1891. PubMed ID: 31564137
[TBL] [Abstract][Full Text] [Related]
28. Cost-Effectiveness Benefits of a Disease Management Program:The REMADHE Trial Results.
Bocchi EA; da Cruz FDD; BrandÃo SM; Issa V; Ayub-Ferreira SM; Brunner la Rocca HP; Wijk SS
J Card Fail; 2018 Oct; 24(10):627-637. PubMed ID: 29723595
[TBL] [Abstract][Full Text] [Related]
29. Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK.
Gutzwiller FS; Schwenkglenks M; Blank PR; Braunhofer PG; Mori C; Szucs TD; Ponikowski P; Anker SD
Eur J Heart Fail; 2012 Jul; 14(7):782-90. PubMed ID: 22689292
[TBL] [Abstract][Full Text] [Related]
30. Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation.
Lau D; Sandhu RK; Andrade JG; Ezekowitz J; So H; Klarenbach S
J Am Heart Assoc; 2021 Jul; 10(14):e019599. PubMed ID: 34238020
[TBL] [Abstract][Full Text] [Related]
31. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.
Adamson PB; Abraham WT; Bourge RC; Costanzo MR; Hasan A; Yadav C; Henderson J; Cowart P; Stevenson LW
Circ Heart Fail; 2014 Nov; 7(6):935-44. PubMed ID: 25286913
[TBL] [Abstract][Full Text] [Related]
32. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
[TBL] [Abstract][Full Text] [Related]
33. Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia.
Bounthavong M; Butler J; Dolan CM; Dunn JD; Fisher KA; Oestreicher N; Pitt B; Hauptman PJ; Veenstra DL
Pharmacoeconomics; 2018 Dec; 36(12):1463-1473. PubMed ID: 30194623
[TBL] [Abstract][Full Text] [Related]
34. The cost effectiveness of ivabradine in the treatment of chronic heart failure from the U.K. National Health Service perspective.
Griffiths A; Paracha N; Davies A; Branscombe N; Cowie MR; Sculpher M
Heart; 2014 Jul; 100(13):1031-6. PubMed ID: 24634022
[TBL] [Abstract][Full Text] [Related]
35. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
36. The Cost-Effectiveness of Palliative Care: Insights from the PAL-HF Trial.
Kaufman BG; Granger BB; Sun JL; Sanders G; Taylor DH; Mark DB; Warraich H; Fiuzat M; Steinhauser K; Tulsky JA; Rogers JG; O'Connor C; Mentz RJ
J Card Fail; 2021 Jun; 27(6):662-669. PubMed ID: 33731305
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness analysis of implantable cardiac devices in patients with systolic heart failure: a US perspective using real world data.
Shah D; Lu X; Paly VF; Tsintzos SI; May DM
J Med Econ; 2020 Jul; 23(7):690-697. PubMed ID: 32207659
[No Abstract] [Full Text] [Related]
38. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.
van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H
Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409
[TBL] [Abstract][Full Text] [Related]
39. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
Lindenfeld J; Zile MR; Desai AS; Bhatt K; Ducharme A; Horstmanshof D; Krim SR; Maisel A; Mehra MR; Paul S; Sears SF; Sauer AJ; Smart F; Zughaib M; Castaneda P; Kelly J; Johnson N; Sood P; Ginn G; Henderson J; Adamson PB; Costanzo MR
Lancet; 2021 Sep; 398(10304):991-1001. PubMed ID: 34461042
[TBL] [Abstract][Full Text] [Related]
40. Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure.
Baras Shreibati J; Goldhaber-Fiebert JD; Banerjee D; Owens DK; Hlatky MA
JACC Heart Fail; 2017 Feb; 5(2):110-119. PubMed ID: 28017351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
